Latest Discussions

Member Spotlight

Latest Specialty News

  • In Brazil, scientists affiliated with the Human Genome and Stem Cell Research Center at the University of São Paulo have identified a molecule capable of reducing the aggressiveness of embryonal central nervous system tumors. These are malignant tumors that start in fetal cells in the brain and mainly affect children up to four years old. The results are published in the journal Molecular Oncology.
  • To ensure that providers stay current in their knowledge of safe chemotherapy and biotherapy administration, APHON requires approved Providers to renew their status every three years. All providers with an expiration date of Dec. 31, 2019 are required to complete the renewal program to maintain their provider status. Renew early and save! Member November Price: $55 Member December Price: $75
  • Why does it hurt? Acute and chronic pain in sickle cell disease Wednesday, December 18th at 1pm CT Presented by Susan Carson, MSN RN CPNP This webinar will review acute pain versus chronic pain syndromes and how they differ in pathophysiology and treatment. This increased understanding of pain in our sickle cell population will lead to improved nursing care and patient outcomes. Learn more and register for this webinar!

Facebook Feed

Twitter Feed

APHON Events

Log in to see this information

Either the content you're seeking doesn't exist or it requires proper authentication before viewing.